Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-076886
Filing Date
2025-08-12
Accepted
2025-08-12 16:38:00
Documents
15
Effectiveness Date
2025-08-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2523289d1_s8.htm S-8 46552
2 EXHIBIT 5.1 tm2523289d1_ex5-1.htm EX-5.1 11112
3 EXHIBIT 23.1 tm2523289d1_ex23-1.htm EX-23.1 2205
4 EXHIBIT 107 tm2523289d1_ex107.htm   iXBRL EX-FILING FEES 16753
5 GRAPHIC image_001.jpg GRAPHIC 2744
  Complete submission text file 0001104659-25-076886.txt   201933

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2523289d1_ex107_htm.xml XML 5346
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289534 | Film No.: 251207370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)